Moelis & Company (NYSE:MC - Free Report) - Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Moelis & Company in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now anticipates that the asset manager will post earnings per share of $0.25 for the quarter, down from their prior forecast of $0.26. The consensus estimate for Moelis & Company's current full-year earnings is $2.97 per share. Zacks Research also issued estimates for Moelis & Company's Q3 2025 earnings at $0.33 EPS, Q4 2025 earnings at $0.57 EPS, FY2025 earnings at $1.80 EPS, Q1 2026 earnings at $0.60 EPS, Q3 2026 earnings at $0.60 EPS, Q4 2026 earnings at $0.66 EPS, FY2026 earnings at $2.41 EPS, Q1 2027 earnings at $0.74 EPS and FY2027 earnings at $3.43 EPS.
Several other brokerages have also issued reports on MC. Morgan Stanley dropped their price target on Moelis & Company from $70.00 to $42.00 and set an "underweight" rating for the company in a research note on Monday, April 7th. JPMorgan Chase & Co. dropped their price target on Moelis & Company from $55.00 to $52.00 and set a "neutral" rating for the company in a research note on Thursday, April 24th. JMP Securities reaffirmed a "market perform" rating on shares of Moelis & Company in a research note on Thursday, April 24th. The Goldman Sachs Group lifted their price target on Moelis & Company from $56.00 to $63.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Finally, StockNews.com lowered Moelis & Company from a "buy" rating to a "hold" rating in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $59.83.
View Our Latest Research Report on MC
Moelis & Company Stock Down 0.8%
Moelis & Company stock opened at $60.95 on Tuesday. Moelis & Company has a 52 week low of $47.00 and a 52 week high of $82.89. The business has a 50-day simple moving average of $55.65 and a 200 day simple moving average of $67.65. The stock has a market cap of $4.79 billion, a price-to-earnings ratio of 34.63 and a beta of 1.66.
Moelis & Company (NYSE:MC - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The asset manager reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.07. The company had revenue of $306.59 million during the quarter, compared to analysts' expectations of $309.67 million. Moelis & Company had a return on equity of 38.49% and a net margin of 11.39%. The firm's quarterly revenue was up 41.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.22 earnings per share.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. CIBC Private Wealth Group LLC grew its stake in shares of Moelis & Company by 52.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 398 shares of the asset manager's stock worth $30,000 after buying an additional 137 shares during the last quarter. Headlands Technologies LLC purchased a new stake in shares of Moelis & Company in the 4th quarter worth approximately $31,000. R Squared Ltd purchased a new stake in shares of Moelis & Company in the 4th quarter worth approximately $47,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of Moelis & Company by 1,551.3% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 644 shares of the asset manager's stock worth $38,000 after buying an additional 605 shares during the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of Moelis & Company by 1,460.8% in the 1st quarter. Versant Capital Management Inc now owns 796 shares of the asset manager's stock worth $46,000 after buying an additional 745 shares during the last quarter. Institutional investors own 91.53% of the company's stock.
Insider Buying and Selling at Moelis & Company
In other Moelis & Company news, Director Kenneth Shropshire sold 2,551 shares of the company's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $72.30, for a total transaction of $184,437.30. Following the completion of the transaction, the director now owns 6,940 shares of the company's stock, valued at $501,762. This represents a 26.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Kenneth Moelis sold 9,712 shares of the company's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $74.00, for a total value of $718,688.00. Following the transaction, the chief executive officer now directly owns 209,235 shares of the company's stock, valued at $15,483,390. The trade was a 4.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,721 shares of company stock valued at $1,677,017 in the last 90 days. Insiders own 6.40% of the company's stock.
Moelis & Company Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Monday, May 5th will be paid a $0.65 dividend. This represents a $2.60 dividend on an annualized basis and a dividend yield of 4.27%. The ex-dividend date is Monday, May 5th. Moelis & Company's dividend payout ratio (DPR) is presently 119.27%.
Moelis & Company Company Profile
(
Get Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.